about
Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in AsiaChronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysisImmuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexusAbsence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centersCorrection: Absence of Antiretroviral Therapy and Other Risk Factors for Morbidity and Mortality in Malaysian Compulsory Drug Detention and Rehabilitation CentersEvolutionary history of HIV-1 subtype B and CRF01_AE transmission clusters among men who have sex with men (MSM) in Kuala Lumpur, MalaysiaComparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian PatientsTrends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational databaseGenetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant LineagesPrevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian FishermenMolecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, MalaysiaProphylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trialPrevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.Estimating the date of origin of an HIV-1 circulating recombinant form.Public health and international drug policy.Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B.Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesisThe TREAT Asia HIV Observational Database: baseline and retrospective data.Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational DatabaseIsolation and characterization of a replication-competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B)Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia.Factors associated with suboptimal adherence to antiretroviral therapy in Asia.Physician Decisions to Defer Antiretroviral Therapy in Key Populations: Implications for Reducing Human Immunodeficiency Virus Incidence and Mortality in Malaysia.Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 geneTrends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational DatabaseTransmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.Patient Characteristics and Treatment Outcome Associated with Protease Inhibitor (PI) use in the Asia-Pacific RegionMycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia.High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study).Safe havens and rough waters: networks, place, and the navigation of risk among injection drug-using Malaysian fishermenCross-border sexual transmission of the newly emerging HIV-1 clade CRF51_01BA clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohortComparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis.HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.Persistent immune activation in chronic HIV infection: do any interventions work?Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.An exploratory qualitative assessment of self-reported treatment outcomes and satisfaction among patients accessing an innovative voluntary drug treatment centre in MalaysiaThe CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.
P50
Q26782701-45894EB7-1DCA-4F2B-B543-F683DBF5D537Q26991791-7617F146-0168-4F6B-8159-1587568109FBQ26991958-E3B285CE-0908-4350-B707-6934B1055F8EQ28483850-94A84D62-68F0-49A0-B55D-34F8250815F1Q28486687-B9D64F09-5449-43C1-B0FA-EC52DCDD7B7EQ28534039-91CAD1F8-97BE-42C4-865F-27CE1CE091A1Q28534376-521425C9-E0EE-4213-A53D-EB083A24369DQ28542731-355734CF-4135-47BF-BD30-B009E8FA97A4Q28546683-A60ADA9D-4187-4A95-8F53-BE4466CC54D4Q28547016-F215FA8C-0843-44C8-B268-ED8C7EDE27C5Q28603737-CA8E24EF-EFD5-49F7-ADFD-CEDDA5358224Q28954574-F4EB79A2-20FC-48D1-B2C8-B39BD40C9AB7Q30248941-31404242-EC12-4C01-AED2-62A1DA3D984FQ30375435-A83216C9-F20B-4D35-A280-170AF73266E0Q30377895-E74F67B4-715D-49EE-9D32-9366D53935A5Q30379106-86A9B9FE-7A77-42C7-973D-CFD837B3C3FBQ30751889-20E6D377-145D-4D9F-B6E2-83448429DC11Q30868237-E47A4E6A-3953-4B01-89F4-09024C2546C9Q30981390-2F28D5CE-3789-44E8-801A-7E9A7EB92B1CQ33433188-F4FCC2D2-79A2-4E85-A1F6-8A0534372EDDQ33494543-496700AD-99B4-41FA-9C0B-4AC163D37E3CQ33560625-B96B7F61-B6BB-468F-8A36-1E21009A7B56Q33626312-E572720B-011B-4E49-9A22-29EAF6AED4ADQ33629465-B3CA202C-2F0D-4198-B3FB-6584E5244E61Q33644568-27EE3D7B-4206-4D23-8135-029905B62292Q33725572-CEAFE12E-3A90-4345-B8E2-DC32EF177AA7Q33779622-C69AAC41-C7A3-409C-912A-F4A659948B5DQ33820125-DF211A2B-84FD-4CB3-BF7A-188702DFEE2BQ33873540-529E55B5-3A27-409F-8AEA-FE07E93F0FD1Q34079505-04AC37D1-BCBE-4BD5-8F02-DB420B873BC8Q34141387-A41C32AC-654A-4546-9A8D-53BA24B63C49Q34148950-63E4C2A1-D3C5-4F7F-8EE8-691BD0C856B5Q34395579-A8088A87-44F3-4984-8FF4-4DA5E09A638CQ34421701-A9C24935-1DAC-4345-A6B9-E0DC6C61346AQ34457230-052C50AF-C8A6-4B74-9A31-1BC028E630F4Q34756828-A7D80024-F262-4E95-804E-8937A06C7908Q34851102-B9959281-485C-4D25-9103-BE01FF54FC1CQ34890135-B8983D86-875E-4C77-A462-5DAD3A703DCBQ34924799-A8C6CDA1-6607-4EE7-9E6D-41F7066E1BFAQ35030351-23582C12-A56E-45B2-83AA-9529B0B162D1
P50
name
Adeeba Kamarulzaman
@ast
Adeeba Kamarulzaman
@en
Adeeba Kamarulzaman
@es
Adeeba Kamarulzaman
@nl
type
label
Adeeba Kamarulzaman
@ast
Adeeba Kamarulzaman
@en
Adeeba Kamarulzaman
@es
Adeeba Kamarulzaman
@nl
prefLabel
Adeeba Kamarulzaman
@ast
Adeeba Kamarulzaman
@en
Adeeba Kamarulzaman
@es
Adeeba Kamarulzaman
@nl